Jennifer brings nearly 27 years of quality, compliance, and regulatory experience in biotechnology and pharmaceutical manufacturing prior to joining WuXi Advanced Therapies, a contract testing, development, and manufacturing organization (CTDMO) in 2020. In her current role, she is supporting many cell and gene therapy clients by interpreting and applying the phase-appropriate GMP regulations and requirements to accelerate development and manufacturing timeline, focusing on client satisfaction and the right-first-time performance. She is passionate about promoting GMP convergence, inspection reliance, and data-driven, risk-based decision-making to maximize patients’ benefit.
.svg)
